Thomas Doerner
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
-
- Cervical Cancer and HPV Research
- Herpesvirus Infections and Treatments
- Nonmelanoma Skin Cancer Studies
Papers in
-
- Rheumatoid Arthritis Research and Therapies 3
-
- Herpesvirus Infections and Treatments 4
- Cervical Cancer and HPV Research 1
- Co-authors
- J. Shoham (4 shared papers)Talia Hahn (1 shared paper)David Wallach (2 shared papers)Hanoch Levavi (1 shared paper)Josef S Smolen (2 shared papers)ISRAEL SAROV (2 shared papers)M Revel (3 shared papers)Eitan Lunenfeld (2 shared papers)
In The Last Decade
Thomas Doerner
17 papers receiving 305 citations
Peers
Comparison fields: 5 of 50
- Rheumatology 66
- Epidemiology 130
- Immunology 66
- Dermatology 23
- Surgery 55
Countries citing papers authored by Thomas Doerner
This map shows the geographic impact of Thomas Doerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Doerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Doerner more than expected).
Fields of papers citing papers by Thomas Doerner
This network shows the impact of papers produced by Thomas Doerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Doerner. The network helps show where Thomas Doerner may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Doerner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 130 | |
| 2 | 2020 | 50 | |
| 3 | 1988 | 35 | |
| 4 | 2021 | 24 | |
| 5 | 2003 | 22 | |
| 6 | 2021 | 16 | |
| 7 | 2004 | 14 | |
| 8 | 2009 | 12 | |
| 9 | Topical application of human fibroblast interferon (IFN) in cutaneous leishmaniasis. | 1987 | 10 |
| 10 | 2016 | 10 | |
| 11 | 1987 | 5 | |
| 12 | 1972 | 4 | |
| 13 | 1987 | 4 | |
| 14 | Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C. | 1985 | 3 |
| 15 | [Beta-interferon for labial and genital herpes virus infection]. | 1989 | 1 |
| 16 | 2001 | 1 | |
| 17 | Modification of the Classification Criteria for Primary Sjogren Syndrome: An International Vignette Survey | 2017 | 1 |
| 18 | 1985 | 0 |
About Thomas Doerner
Thomas Doerner is a scholar working on Rheumatology, Epidemiology, Immunology, Physiology and Dermatology, having authored 18 papers that have together received 342 indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Salivary Gland Disorders and Functions (2 papers), Cervical Cancer and HPV Research (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), Bacteriophages and microbial interactions (1 paper), Helicobacter pylori-related gastroenterology studies (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Rheumatology (66 citations), Epidemiology (130 citations), Immunology (66 citations), Dermatology (23 citations) and Surgery (55 citations). Thomas Doerner has collaborated with scholars based in Germany, Israel and France. Frequent co-authors include J. Shoham, Talia Hahn, David Wallach, Hanoch Levavi, Josef S Smolen, ISRAEL SAROV, M Revel, Eitan Lunenfeld, Marek Glezerman and Klaus H. Geissler. Their work appears in journals such as The Lancet, RMD Open, The Journal of Rheumatology, Pediatric Research and Medical Microbiology and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.